BioCanvas
표적 · CD178

CD178 항체

6최다 인용
25인용된 항체
6벤더
Antibody Registry데이터 출처 · RRID CC0

논문 인용순 항체

Antibody Registry 인용수 기준 · 25종
1
BioLegend#106606 (also 106605) RRID:AB_313279 monoclonal
6
cited by
2
BioLegend#306407 (also 306406) RRID:AB_2100664 monoclonal
3
cited by
3
BD Biosciences#564261 RRID:AB_2738713 monoclonal
3
cited by
4
BioLegend#106605 (also 106606) RRID:AB_313278 monoclonal
2
cited by
5
BD Biosciences#555293 RRID:AB_395711 monoclonal
2
cited by
6
Santa Cruz Biotechnology#sc-6237 RRID:AB_2246664 polyclonal
2
cited by
7
BioLegend#306411 (also 306412) RRID:AB_2716104 monoclonal
2
cited by
8
BD Biosciences#564262 RRID:AB_2738714 monoclonal
2
cited by
9
Miltenyi Biotec#130-096-458 RRID:AB_10827748 monoclonal
2
cited by
10
BioLegend#106603 RRID:AB_313276 monoclonal
1
cited by
11
BioLegend#306402 RRID:AB_314600 monoclonal
1
cited by
12
BD Biosciences#555022 RRID:AB_395653 monoclonal
1
cited by
13
BD Biosciences#555290 RRID:AB_395708 monoclonal
1
cited by
14
BD Biosciences#555292 RRID:AB_395710 monoclonal
1
cited by
15
BD Biosciences#556387 RRID:AB_396402 monoclonal
1
cited by
16
Thermo Fisher Scientific#16-5911-81 RRID:AB_469145 monoclonal
1
cited by
17
Thermo Fisher Scientific#16-9919-81 RRID:AB_469281 monoclonal
1
cited by
18
Cell Signaling Technology#4273 RRID:AB_2100652 unknown
1
cited by
19
Thermo Fisher Scientific#A15381 RRID:AB_2534395 monoclonal
1
cited by
20
BioLegend#306413 RRID:AB_2750500 monoclonal
1
cited by
21
Miltenyi Biotec#130-118-491 RRID:AB_2751526 monoclonal
1
cited by
22
BioLegend#306415 (also 306416) RRID:AB_2810458 monoclonal
1
cited by
23
BioLegend#306416 (also 306415) RRID:AB_2810459 monoclonal
1
cited by
24
BioLegend#106612 (also 106611) RRID:AB_2813954 monoclonal
1
cited by
25
Miltenyi Biotec#130-126-491 RRID:AB_2889479 monoclonal
1
cited by
이 표적 항체를 국내 공급가·납기로 확인하시겠어요? 국내 구매·견적 문의 →

CD178

이 표적에 논문에서 가장 많이 인용된 항체 순으로 정리했습니다. 각 행에서 국내 견적을 요청할 수 있습니다.

Data: Antibody Registry (SciCrunch) — RRID under CC-0; product metadata per respective source. Citation counts: Antibody Registry.